{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:30:02Z","timestamp":1772116202587,"version":"3.50.1"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2022,6,1]]},"DOI":"10.1001\/jamadermatol.2022.0055","type":"journal-article","created":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T14:30:30Z","timestamp":1648305030000},"page":"611","source":"Crossref","is-referenced-by-count":9,"title":["Rubella Virus\u2013Associated Granulomas in Immunocompetent Adults\u2014Possible Implications"],"prefix":"10.1001","volume":"158","author":[{"given":"Luigi D.","family":"Notarangelo","sequence":"first","affiliation":[{"name":"Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"6","key":"ded220001r1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s10875-018-0534-7","article-title":"Prevalence of granulomas in patients with primary immunodeficiency disorders, United States: data from national health care claims and the US Immunodeficiency Network Registry.","volume":"38","author":"Leung","year":"2018","journal-title":"J Clin Immunol"},{"key":"ded220001r2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.0828","article-title":"Association of rubella virus with idiopathic skin granulomas in clinically immunocompetent adults.","author":"Wanat","journal-title":"JAMA Dermatol"},{"issue":"12","key":"ded220001r3","doi-asserted-by":"publisher","first-page":"S360","DOI":"10.1093\/infdis\/jiaa530","article-title":"Rubella eradication: not yet accomplished, but entirely feasible.","volume":"224","author":"Plotkin","year":"2021","journal-title":"J Infect Dis"},{"issue":"10","key":"ded220001r4","doi-asserted-by":"publisher","first-page":"O656","DOI":"10.1111\/1469-0691.12573","article-title":"Live rubella virus vaccine long-term persistence as an antigenic trigger of cutaneous granulomas in patients with primary immunodeficiency.","volume":"20","author":"Bodemer","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"ded220001r5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/cid\/ciw675","article-title":"Cutaneous and visceral chronic granulomatous disease triggered by a rubella virus vaccine strain in children with primary immunodeficiencies.","volume":"64","author":"Neven","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ded220001r6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10875-018-0581-0","article-title":"Rubella virus\u2013associated cutaneous granulomatous disease: a unique complication in immune-deficient patients, not limited to DNA repair disorders.","volume":"39","author":"Buchbinder","year":"2019","journal-title":"J Clin Immunol"},{"issue":"6","key":"ded220001r7","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/ACI.0000000000000694","article-title":"Rubella virus-associated chronic inflammation in primary immunodeficiency diseases.","volume":"20","author":"Perelygina","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ded220001r8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.796065","article-title":"Rubella virus infected macrophages and neutrophils define patterns of granulomatous inflammation in inborn and acquired errors of immunity.","volume":"12","author":"Perelygina","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"ded220001r9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jaci.2021.05.007","article-title":"Rubella vaccine-induced granulomas are a novel phenotype with incomplete penetrance of genetic defects in cytotoxicity.","volume":"149","author":"Gro\u00df","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"ded220001r10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008080","article-title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies.","volume":"15","author":"Perelygina","year":"2019","journal-title":"PLoS Pathog"},{"issue":"62","key":"ded220001r11","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl4340","article-title":"Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.","volume":"6","author":"Bastard","year":"2021","journal-title":"Sci Immunol"},{"issue":"4","key":"ded220001r12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202486","article-title":"Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine.","volume":"218","author":"Bastard","year":"2021","journal-title":"J Exp Med"},{"issue":"5","key":"ded220001r13","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.jaci.2016.06.030","article-title":"Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies.","volume":"138","author":"Perelygina","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"ded220001r14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ebiom.2015.11.050","article-title":"Immunolocalization and distribution of rubella antigen in fatal congenital rubella syndrome.","volume":"3","author":"Lazar","year":"2015","journal-title":"EBioMedicine"},{"issue":"7","key":"ded220001r15","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1001\/jamadermatol.2021.1577","article-title":"Granulomatous dermatitis associated with rubella virus infection in an adult with immunodeficiency.","volume":"157","author":"Shields","year":"2021","journal-title":"JAMA Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2790588\/jamadermatology_notarangelo_2022_ed_220001_1654530073.56456.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T15:04:24Z","timestamp":1655305464000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2790588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2022.0055","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}